Deucravacitinib onset of action and maintenance of response in phase 3 plaque psoriasis trials
Korman, Neil J, Warren, Richard B, Bagel, Jerry, Armstrong, April W, Gooderham, Melinda, Strober, Bruce, Thaçi, Diamant, Morita, Akimichi, Imafuku, Shinichi, Foley, Peter, Sofen, Howard, Zheng, Min, Hippeli, Lauren, Kisa, Renata M, Banerjee, Subhashis, Blauvelt, Andrew
Published in The Journal of dermatological treatment (01.12.2024)
Published in The Journal of dermatological treatment (01.12.2024)
Get full text
Journal Article
Deucravacitinib Improves Patient-Reported Outcomes in Patients with Moderate to Severe Psoriasis: Results from the Phase 3 Randomized POETYK PSO-1 and PSO-2 Trials
Armstrong, April W., Augustin, Matthias, Beaumont, Jennifer L., Pham, Tan P., Hudgens, Stacie, Gordon, Kenneth B., Zhuo, Joe, Becker, Brandon, Zhong, Yichen, Kisa, Renata M., Banerjee, Subhashis, Papp, Kim A.
Published in Dermatology and therapy (01.08.2024)
Published in Dermatology and therapy (01.08.2024)
Get full text
Journal Article
Deucravacitinib in plaque psoriasis: 2-year safety and efficacy results from the phase III POETYK trials
Lebwohl, Mark, Warren, Richard B, Sofen, Howard, Imafuku, Shinichi, Paul, Carle, Szepietowski, Jacek C, Spelman, Lynda, Passeron, Thierry, Vritzali, Eleni, Napoli, Andrew, Kisa, Renata M, Buck, Alex, Banerjee, Subhashis, Thaçi, Diamant, Blauvelt, Andrew
Published in British journal of dermatology (1951) (17.04.2024)
Published in British journal of dermatology (1951) (17.04.2024)
Get full text
Journal Article
Deucravacitinib in moderate‐to‐severe plaque psoriasis: Pooled safety and tolerability over 52 weeks from two phase 3 trials (POETYK PSO‐1 and PSO‐2)
Strober, Bruce, Blauvelt, Andrew, Warren, Richard B., Papp, Kim A., Armstrong, April W., Gordon, Kenneth B., Morita, Akimichi, Alexis, Andrew F., Lebwohl, Mark, Foley, Peter, Kisa, Renata M., Colston, Elizabeth, Wang, Tao, Banerjee, Subhashis, Thaçi, Diamant
Published in Journal of the European Academy of Dermatology and Venereology (01.08.2024)
Published in Journal of the European Academy of Dermatology and Venereology (01.08.2024)
Get full text
Journal Article
Deucravacitinib in Moderate to Severe Psoriasis: Clinical and Quality-of-Life Outcomes in a Phase 2 Trial
Thaçi, Diamant, Strober, Bruce, Gordon, Kenneth B., Foley, Peter, Gooderham, Melinda, Morita, Akimichi, Papp, Kim A., Puig, Lluís, Menter, M. Alan, Colombo, Matthew J., Elbez, Yedid, Kisa, Renata M., Ye, June, Napoli, Andrew A., Wei, Lan, Banerjee, Subhashis, Merola, Joseph F., Gottlieb, Alice B.
Published in Dermatology and therapy (01.02.2022)
Published in Dermatology and therapy (01.02.2022)
Get full text
Journal Article
51214 Deucravacitinib efficacy in palmoplantar and fingernail psoriasis by baseline Psoriasis Area and Severity Index (PASI) and baseline body surface area (BSA) in the phase 3 POETYK PSO-1 and PSO-2 trials
Elewski, Boni, Lambert, Jo, Merola, Joseph F., Lebwohl, Mark, Hoyt, Kim, Kisa, Renata M., Banerjee, Subhashis, Scharnitz, Thomas, Cather, Jennifer
Published in Journal of the American Academy of Dermatology (01.09.2024)
Published in Journal of the American Academy of Dermatology (01.09.2024)
Get full text
Journal Article
P096 Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 (TYK2) inhibitor, in moderate-to-severe plaque psoriasis: safety profile in older (≥ 65 years) and younger (< 65 years) patients in the phase III POETYK PSO-1, PSO-2 and long-term extension trials
Kearney, Niamh, Pink, Andrew, Hoyt, Kim, Kisa, Renata M, Banerjee, Subhashis, Rogers, Alexandra, Mullan, Jill, Warren, Richard B
Published in British journal of dermatology (1951) (28.06.2024)
Published in British journal of dermatology (1951) (28.06.2024)
Get full text
Journal Article
43872 Deucravacitinib, an Oral, Selective, Allosteric Tyrosine Kinase 2 Inhibitor, in Scalp, Nail, and Palmoplantar Psoriasis in Japanese Patients With Plaque Psoriasis: Subset Analysis of the Phase 3 POETYK PSO-4 Trial
Imafuku, Shinichi, Okubo, Yukari, Tada, Yayoi, Ohtsuki, Mamitaro, Shao, Yanqiu, Colston, Elizabeth, Kisa, Renata M., Banerjee, Subhashis, Morita, Akimichi
Published in Journal of the American Academy of Dermatology (01.09.2023)
Published in Journal of the American Academy of Dermatology (01.09.2023)
Get full text
Journal Article
51109 Efficacy of deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 (TYK2) inhibitor, in scalp psoriasis by baseline Psoriasis Area and Severity Index (PASI) and baseline body surface area (BSA): A subanalysis of the phase 3 clinical trial data
Blauvelt, Andrew, Sofen, Howard, Lambert, Jo, Merola, Joseph F., Lebwohl, Mark, Hoyt, Kim, Kisa, Renata M., Banerjee, Subhashis, Scharnitz, Thomas, Crowley, Jeffrey J.
Published in Journal of the American Academy of Dermatology (01.09.2024)
Published in Journal of the American Academy of Dermatology (01.09.2024)
Get full text
Journal Article
51091 Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in plaque psoriasis: 3-year Psoriasis Area and Severity Index (PASI) outcomes in the long-term extension of the phase 3 POETYK PSO-1 and PSO-2 trials
Gold, Linda Stein, Banerjee, Subhashis, Colombo, Matthew J., Kisa, Renata M., Berger, Victoria, Hoyt, Kim, Soung, Jennifer, Torres, Tiago, Bhatia, Neal, Glick, Brad P., Kaufmann, Mark D.
Published in Journal of the American Academy of Dermatology (01.09.2024)
Published in Journal of the American Academy of Dermatology (01.09.2024)
Get full text
Journal Article
43851 Deucravacitinib Long-term Efficacy With Continuous Treatment in Plaque Psoriasis: 2-Year Results From the Phase 3 POETYK PSO-1 and POETYK PSO-LTE Trials
Lebwohl, Mark, Warren, Richard B., Kircik, Leon, Colston, Elizabeth, Hippeli, Lauren, Napoli, Andrew, Kisa, Renata M., Banerjee, Subhashis, Menter, Alan, Thaçi, Diamant, Blauvelt, Andrew
Published in Journal of the American Academy of Dermatology (01.09.2023)
Published in Journal of the American Academy of Dermatology (01.09.2023)
Get full text
Journal Article
P77 Deucravacitinib, an oral selective allosteric tyrosine kinase 2 inhibitor, vs. placebo and apremilast in moderate-to-severe plaque psoriasis: achievement of absolute Psoriasis Area and Severity Index thresholds in two phase III trials
Warren, Richard B, Lebwohl, Mark, Gooderham, Melinda, Thaci, Diamant, Foley, Peter, Gottlieb, Alice B, Banerjee, Subhashis, Hippeli, Lauren, Kisa, Renata M, Griffiths, Christopher E M
Published in British journal of dermatology (1951) (26.06.2023)
Published in British journal of dermatology (1951) (26.06.2023)
Get full text
Journal Article
Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in patients from China mainland, Taiwan, and South Korea with moderate to severe plaque psoriasis: a phase 3 randomized clinical trial
Zhang, Jianzhong, Ding, Yangfeng, Wang, Ping, Li, Linfeng, Pan, Weili, Lu, Yan, Cheng, Hao, Jiang, Xian, Ho, Ji-Chen, Guo, Shuping, Liu, Leona, Chatterjee, Arkendu, Kisa, Renata M, Banerjee, Subhashis
Published in British journal of dermatology (1951) (22.10.2024)
Published in British journal of dermatology (1951) (22.10.2024)
Get full text
Journal Article
35205 Deucravacitinib improves Dermatology Life Quality Index (DLQI) in patients with moderate to severe psoriasis: Results from the phase 3 POETYK PSO-1 and PSO-2 trials
Augustin, Matthias, Strober, Bruce, Armstrong, April W., Beaumont, Jennifer, Pham, Tan P., Hudgens, Stacie, Zhuo, Joe, Becker, Brandon, Banerjee, Subhashis, Kisa, Renata M., Papp, Kim
Published in Journal of the American Academy of Dermatology (01.09.2022)
Published in Journal of the American Academy of Dermatology (01.09.2022)
Get full text
Journal Article
13601 BMS-986165, an oral selective TYK2 inhibitor, in the treatment of moderate to severe psoriasis as assessed by the static Physicians Global Assessment/body surface area composite tool, a clinically useful alternative to the Psoriasis Area and Severity Index score
Gottlieb, Alice, Strober, Bruce, Thaci, Diamant, Gordon, Kenneth, Ren, Haobo, Kisa, Renata M., Wei, Lan, Banerjee, Subhashis, Merola, Joseph F.
Published in Journal of the American Academy of Dermatology (01.12.2020)
Published in Journal of the American Academy of Dermatology (01.12.2020)
Get full text
Journal Article
Deucravacitinib in moderate to severe plaque psoriasis: liver transaminase results from the phase 3 POETYK PSO program
Lebwohl, Mark, Egeberg, Alexander, Linaberry, Misti, Hoyt, Kim, Banerjee, Subhashis, Kisa, Renata M., Strober, Bruce
Published in Skin (Milwood, N.Y.) (13.03.2023)
Published in Skin (Milwood, N.Y.) (13.03.2023)
Get full text
Journal Article
Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in moderate to severe plaque psoriasis: evaluation of lipid parameters in the phase 3 POETYK PSO-1 and PSO-2 trials
Lebwohl, Mark, Strober, Bruce, Linaberry, Misti, Hoyt, Kim, Banerjee, Subhashis, Kisa, Renata M., Mehta, Nehal N.
Published in Skin (Milwood, N.Y.) (13.03.2023)
Published in Skin (Milwood, N.Y.) (13.03.2023)
Get full text
Journal Article
Deucravacitinib, an Oral, Selective, Allosteric Tyrosine Kinase 2 Inhibitor, in Moderate to Severe Plaque Psoriasis: Evaluation of Creatine Phosphokinase Elevations in the Phase 3 POETYK PSO-1 and PSO-2 Trials
Lebwohl, Mark, Strober, Bruce, Scharnitz, Thomas, Linaberry, Misti, Hoyt, Kim, Banerjee, Subhashis, Kisa, Renata M., Martin, George
Published in Skin (Milwood, N.Y.) (13.11.2023)
Published in Skin (Milwood, N.Y.) (13.11.2023)
Get full text
Journal Article
Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in moderate to severe plaque psoriasis: efficacy by baseline body surface area (BSA) involvement and baseline Psoriasis Area and Severity Index (PASI)
Armstrong, April W., Lebwohl, Mark, Bagel, Jerry, Schlesinger, Todd, Banerjee, Subhashis, Kisa, Renata M., Scharnitz, Thomas, Hoyt, Kim, Strober, Bruce
Published in Skin (Milwood, N.Y.) (13.03.2023)
Published in Skin (Milwood, N.Y.) (13.03.2023)
Get full text
Journal Article
Deucravacitinib Long-term Efficacy With Continuous Treatment in Plaque Psoriasis: 2-Year Results From the Phase 3 POETYK PSO-1 and PSO-2 Trials
Thaçi, Diamant, Lebwohl, Mark, Warren, Richard B., Kircik, Leon, Banerjee, Subhashis, Napoli, Andrew, Kisa, Renata M., Linaberry, Misti, Hoyt, Kim, Blauvelt, Andrew
Published in Skin (Milwood, N.Y.) (13.11.2023)
Published in Skin (Milwood, N.Y.) (13.11.2023)
Get full text
Journal Article